A carregar...
Belinostat in patients with refractory or relapsed peripheral T-cell lymphoma: a perspective review
Peripheral T-cell lymphoma (PTCL) is a disease with poor prognosis and limited treatment options. Recent advances in cancer biology suggest that PTCL may be characterized by gross epigenetic dysregulation, which may help explain its sensitivity to histone deacetylase (HDAC) inhibitors. HDAC inhibito...
Na minha lista:
| Publicado no: | Ther Adv Hematol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4530372/ https://ncbi.nlm.nih.gov/pubmed/26288714 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620715592567 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|